Literature DB >> 2097672

In vivo measures of monoamines during amphetamine-induced behaviors in rats.

R Kuczenski1, D S Segal.   

Abstract

1. Using a removable in vivo microdialysis probe, and remote sample collection, the temporal and dose-related behavioral and monoamine response to amphetamine (AMPH) were examined in freely-moving rats. Extracellular dopamine, serotonin and their metabolites were monitored concomitant with detailed characterization of the locomotor and stereotypy profiles. Consistent with previous results, AMPH (0.5-5.0 mg/kg) induced a rapid dose-dependent increase in dopamine concentration and decrease in the concentrations of the dopamine metabolites. Dopamine and metabolites exhibited contrasting temporal and dose-related patterns, suggesting that the decline in dopamine metabolites is functionally dissociated from the AMPH-enhanced dopamine release, and that metabolite levels do not provide an accurate index of functional dopaminergic activity. 2. Dose response comparisons revealed a significant relationship between AMPH-induced increases in behavioral perseveration and the magnitude and duration of the dopamine release. However, the temporal patterns of the neurotransmitter response and individual components of stereotypy were not parallel, suggesting that the presence of stereotypies is not associated simply with quantitative differences in striatal dopamine release. 3. Consistent with this interpretation, we found that a variety of manipulations including reserpine, apomorphine, and chronic amphetamine pretreatment, produced a dissociation between the alterations in the behavioral and dopaminergic responses to amphetamine. The behavioral response to amphetamine may be influenced by the interaction between levels of dopamine and serotonin, by the state of their respective receptors, and by the relative contributions of additional dopaminergic systems.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2097672     DOI: 10.1016/0278-5846(90)90085-u

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  7 in total

1.  An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics.

Authors:  D S Segal; R Kuczenski
Journal:  J Neurosci       Date:  1997-04-01       Impact factor: 6.167

2.  Quantitative trait loci affecting methamphetamine responses in BXD recombinant inbred mouse strains.

Authors:  J E Grisel; J K Belknap; L A O'Toole; M L Helms; C D Wenger; J C Crabbe
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

Review 3.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

4.  Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction.

Authors:  L M Moran; R M Booze; K M Webb; C F Mactutus
Journal:  Exp Neurol       Date:  2012-10-11       Impact factor: 5.330

5.  Maternal high fat diet during the perinatal period alters mesocorticolimbic dopamine in the adult rat offspring: reduction in the behavioral responses to repeated amphetamine administration.

Authors:  Lindsay Naef; Lalit Srivastava; Alain Gratton; Howard Hendrickson; S Michael Owens; Claire-Dominique Walker
Journal:  Psychopharmacology (Berl)       Date:  2007-11-16       Impact factor: 4.530

Review 6.  Behavioral sensitization and tolerance to cocaine and the occupation of dopamine receptors by dopamine.

Authors:  M T Martin-Iverson; L Y Burger
Journal:  Mol Neurobiol       Date:  1995 Aug-Dec       Impact factor: 5.590

7.  Interaction between the noradrenergic and serotonergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats.

Authors:  A Muñoz; A Lopez-Real; J L Labandeira-Garcia; M J Guerra
Journal:  Exp Brain Res       Date:  2003-08-29       Impact factor: 1.972

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.